Correlation Between Seres Therapeutics and Nuvation Bio
Can any of the company-specific risk be diversified away by investing in both Seres Therapeutics and Nuvation Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Seres Therapeutics and Nuvation Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Seres Therapeutics and Nuvation Bio, you can compare the effects of market volatilities on Seres Therapeutics and Nuvation Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Seres Therapeutics with a short position of Nuvation Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Seres Therapeutics and Nuvation Bio.
Diversification Opportunities for Seres Therapeutics and Nuvation Bio
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Seres and Nuvation is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Seres Therapeutics and Nuvation Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvation Bio and Seres Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Seres Therapeutics are associated (or correlated) with Nuvation Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvation Bio has no effect on the direction of Seres Therapeutics i.e., Seres Therapeutics and Nuvation Bio go up and down completely randomly.
Pair Corralation between Seres Therapeutics and Nuvation Bio
Given the investment horizon of 90 days Seres Therapeutics is expected to generate 1.18 times more return on investment than Nuvation Bio. However, Seres Therapeutics is 1.18 times more volatile than Nuvation Bio. It trades about -0.05 of its potential returns per unit of risk. Nuvation Bio is currently generating about -0.15 per unit of risk. If you would invest 93.00 in Seres Therapeutics on December 1, 2024 and sell it today you would lose (17.00) from holding Seres Therapeutics or give up 18.28% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Seres Therapeutics vs. Nuvation Bio
Performance |
Timeline |
Seres Therapeutics |
Nuvation Bio |
Seres Therapeutics and Nuvation Bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Seres Therapeutics and Nuvation Bio
The main advantage of trading using opposite Seres Therapeutics and Nuvation Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Seres Therapeutics position performs unexpectedly, Nuvation Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvation Bio will offset losses from the drop in Nuvation Bio's long position.Seres Therapeutics vs. Syros Pharmaceuticals | Seres Therapeutics vs. Iovance Biotherapeutics | Seres Therapeutics vs. Veracyte | Seres Therapeutics vs. Fate Therapeutics |
Nuvation Bio vs. Assembly Biosciences | Nuvation Bio vs. Instil Bio | Nuvation Bio vs. Achilles Therapeutics PLC | Nuvation Bio vs. NextCure |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Transaction History View history of all your transactions and understand their impact on performance | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |